UA91615U - Polyvalent vaccine against leptospirosis of animals (variant equi) - Google Patents

Polyvalent vaccine against leptospirosis of animals (variant equi)

Info

Publication number
UA91615U
UA91615U UAU201401450U UAU201401450U UA91615U UA 91615 U UA91615 U UA 91615U UA U201401450 U UAU201401450 U UA U201401450U UA U201401450 U UAU201401450 U UA U201401450U UA 91615 U UA91615 U UA 91615U
Authority
UA
Ukraine
Prior art keywords
equi
animals
variant
vaccine against
polyvalent vaccine
Prior art date
Application number
UAU201401450U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Вікторія Олександрівна Волинець
Віталій Вікторович Уховський
Олександр Олександрович Кучерявенко
Влада Вячеславівна Куликова
Галина Василівна Дяченко
Original Assignee
Інститут Ветеринарної Медицини Національної Академії Аграрних Наук України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Ветеринарної Медицини Національної Академії Аграрних Наук України filed Critical Інститут Ветеринарної Медицини Національної Академії Аграрних Наук України
Priority to UAU201401450U priority Critical patent/UA91615U/en
Publication of UA91615U publication Critical patent/UA91615U/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

A polyvalent vaccine against leptospirosis of the animals (variant EQUI) contains the antigens of Leptospira interrogans strains of the following serogroups: Grippotyphosa (strain VGNKI-1), Icterohaemorrhagiae (strain VGNKI-2), Canicola (strain VGNKI-3), Australis (strain Yez ) at the following ratios, in percents:formalin as inactivator, poliethylenglycol as sorbent and adjuvant, and water.
UAU201401450U 2014-02-14 2014-02-14 Polyvalent vaccine against leptospirosis of animals (variant equi) UA91615U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201401450U UA91615U (en) 2014-02-14 2014-02-14 Polyvalent vaccine against leptospirosis of animals (variant equi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201401450U UA91615U (en) 2014-02-14 2014-02-14 Polyvalent vaccine against leptospirosis of animals (variant equi)

Publications (1)

Publication Number Publication Date
UA91615U true UA91615U (en) 2014-07-10

Family

ID=56282452

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201401450U UA91615U (en) 2014-02-14 2014-02-14 Polyvalent vaccine against leptospirosis of animals (variant equi)

Country Status (1)

Country Link
UA (1) UA91615U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2702835C1 (en) * 2015-10-08 2019-10-11 Мериал, Инк. Live attenuated heterologous leptospira vaccine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2702835C1 (en) * 2015-10-08 2019-10-11 Мериал, Инк. Live attenuated heterologous leptospira vaccine

Similar Documents

Publication Publication Date Title
MX2021000285A (en) Compositions comprising bacterial strains.
WO2016019134A8 (en) Flagellin-based agents and uses including effective vaccination
MX2022002106A (en) Single vial vaccine formulations.
MX2016016746A (en) Dual adjuvant vaccine compositions, preparation and uses.
SG11202003800YA (en) Zika vaccines and immunogenic compositions, and methods of using the same
AR091582A1 (en) VACCINES ATTENDED AGAINST STREPTOCOCCUS SUIS AND METHODS OF ELABORATION AND USE OF THE SAME
ZA201902563B (en) Expec glycoconjugate vaccine formulations
NZ715459A (en) A hyperbarically-inactivated microorganism, immunogenic compositions comprising same and methods for producing same
MX2023012390A (en) Vaccination with replicon particles and oil adjuvant.
EP3308800A4 (en) Adjuvant for vaccines, vaccine, and immunity induction method
SG11202004863QA (en) Zika vaccines and immunogenic compositions, and methods of using the same
ZA202000574B (en) Mesenchymal stem cells as vaccine adjuvants and methods for using the same
CL2018000513A1 (en) Pestivirus vaccines for congenital tremors
EP3538197A4 (en) Devices and methods for enhancing immunogenicity to intradermal vaccination
UA91615U (en) Polyvalent vaccine against leptospirosis of animals (variant equi)
GB2515222A (en) Use of flagellin as a vaccine
UY36208A (en) "MODIFIED BACTERIA FOR IMPROVED VACCINES AGAINST BRUCELOSIS".
CL2017000555A1 (en) Multivalent brucella vaccine for protection against mycobacterial infections and methods for its use.
GB2530210A (en) Novel piscirickettsia salmonis isolate
NZ734938A (en) Leptospira immunoprotective proteins and methods of identification and use thereof
UA73324U (en) polyvalent vaccine against animal leptospirosis (version bovis)
MX2018003173A (en) Salmonella choleraesuis-salmonella typhimurium vaccines.
AU2019268149A1 (en) Live attenuated heterologous vaccine for Leptospira
EP3615006A4 (en) Antigenic thermostable polio vaccines&related methods
AR101124A1 (en) MODIFIED BACTERIA FOR IMPROVED VACCINES AGAINST BRUCELOSIS